If you have been reading about alpha-MSH analogue and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-12. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The ionic nature of proteins was demonstrated by Bjerrum, Weber and Arne Tiselius, but Linderstrom-Lang showed that the charges were generally accessible to solvent and not bound to each other (1949). The secondary and low-resolution tertiary structure of globular proteins was investigated initially by hydrodynamic methods, such as analytical ultracentrifugation and flow birefringence. Spectroscopic methods to probe protein structure (such as circular dichroism, fluorescence, near-ultraviolet and infrared absorbance) were developed in the 1950s. The first atomic-resolution structures of proteins were solved by X-ray crystallography in the 1960s and by NMR in the 1980s. As of 2019, the Protein Data Bank has over 150,000 atomic-resolution structures of proteins. In more recent times, cryo-electron microscopy of large macromolecular assemblies has achieved atomic resolution, and computational protein structure prediction of small protein domains is approaching atomic resolution.
== Plasma processing == When the ultimate goal of plasma processing is a purified plasma component for injection or transfusion, the plasma component must be highly pure. The first practical large-scale method of blood plasma fractionation was developed by Edwin J. Cohn during World War II. It is known as the Cohn process (or Cohn method). This process is also known as cold ethanol fractionation as it involves gradually increasing the concentration of ethanol in the solution at 5 °C and 3 °C. The Cohn Process exploits differences in properties of the various plasma proteins, specifically, the high solubility and low pI of albumin. As the ethanol concentration is increased in stages from 0% to 40% the [pH] is lowered from neutral (pH ~ 7) to about 4.8, which is near the pI of albumin. At each stage certain proteins are precipitated out of the solution and removed. The final precipitate is purified albumin. Several variations to this process exist, including an adapted method by Nitschmann and Kistler that uses fewer steps and replaces centrifugation and bulk freezing with filtration and diafiltration. Some newer methods of albumin purification add additional purification steps to the Cohn Process and its variations, while others incorporate chromatography, with some methods being purely chromatographic. Chromatographic albumin processing as an alternative to the Cohn Process emerged in the early 1980s, however, it was not widely adopted until later due to the inadequate availability of large scale chromatography equipment.
The Jalisco New Generation Cartel (Spanish: Cártel de Jalisco Nueva Generación, pronounced [ˈkaɾtel ðe xaˈlisko ˈnweβa xeneɾaˈsjon]), also known as CJNG, is a Mexican criminal syndicate based in Jalisco founded and headed by Nemesio Oseguera Cervantes, commonly known as El Mencho, until he was killed by the Mexican Army in 2026. The cartel has been characterized by extreme violence and public relations campaigns. Though the CJNG is known for diversifying into various criminal rackets, drug trafficking (primarily cocaine and methamphetamine) remains its most profitable activity. The cartel has been noted for cannibalizing victims during the training of newly inducted sicarios or members, as well as using drones and rocket-propelled grenades to attack rival groups. CJNG started in 2009 as a splinter group of the Milenio Cartel, the other being La Resistencia. CJNG defeated La Resistencia and took control of Milenio's smuggling networks. CJNG expanded its operation network from coast to coast in six months, making it one of the criminal groups with the greatest operating capacity by 2012. Following the emergence of the cartel, homicides, kidnappings and discoveries of mass graves spiked in Jalisco. By 2018, the CJNG was believed to have over 100 methamphetamine labs throughout Mexico. Based on average street value, its trade could net upwards of $8 billion for cocaine and $4.6 billion for crystal meth each year.
== Medicine == An exudate is any fluid that filters from the circulatory system into lesions or areas of inflammation. It can be a pus-like or clear fluid. When an injury occurs, leaving skin exposed, it leaks out of the blood vessels and into nearby tissues. The fluid is composed of serum, fibrin, and leukocytes. Exudate may ooze from cuts or from areas of infection or inflammation. Although blood itself is not an exudate, some types of exudates contain blood cells.
On September 9, 2025, Talarico announced his candidacy for the 2026 U.S. Senate election in Texas. He and U.S. Representative Jasmine Crockett vied for the Democratic nomination. In February 2026, the Houston Chronicle, the Austin American-Statesman, The Dallas Morning News, and the Fort Worth Star-Telegram endorsed Talarico. Later in February, the FCC opened an investigation into Talarico's appearance on The View, citing a potential violation of the equal-time rule. Late-night and talk shows were exempt from the requirement until an FCC rule change in January 2026. On February 16, 2026, Talarico was scheduled to appear on The Late Show with Stephen Colbert. Colbert said CBS canceled the interview because of the Trump administration's "intensifying pressure against broadcast TV networks". He said the network's lawyers had instructed him not to have Talarico on the show or mention the cancellation. Against their advice, he interviewed Talarico and spoke publicly about the cancellation. Colbert accused CBS of censorship and posted the interview to the show's YouTube page instead, where it had gained 7.3 million views by February 18, making it the most viewed interview segment on The Late Show's channel in a year. On March 3, Talarico won the Democratic primary, securing the party's nomination in the November general election. In the general election, he faces Texas Attorney General Ken Paxton, who won the Republican primary runoff on May 26. Former President Barack Obama appeared at an event with Talarico in May 2026.
Sources: en.wikipedia.org
=== Moritz-Hunter Bauer === Moritz-Hunter Bauer (Sid Phoenix) is the heir to the Austrian banking family behind IBN Bauer, with which Tender pursues a merger. He raises objections to the deal on data privacy and regulatory grounds, prompting Henry Muck and Whitney Halberstram, Tender's CEO and CFO respectively, to visit his family's castle in Vienna along with Yasmin to negotiate with him. Although Moritz presents his concerns as principled scrutiny, his views increasingly take on fascist overtones: he articulates a critique of liberal democracy and free-market capitalism and instead expresses admiration for authoritarian models of governance, citing Louis XIV as a political inspiration. He also makes an antisemitic insinuation at Whitney during dinner. Henry and Whitney decide not to continue engaging with him, but Yasmin makes a deal with Princess Johanna Bauer, Moritz's mother, to publish Moritz's views in one of Lord Norton's papers in exchange for his backing the merger. The next day, Moritz's article outlining his views, "The Case for a Benevolent Dictatorship", is published in a national column. Moritz and Johanna later attend Yasmin's fundraiser dinner in Paris for far-right MP Sebastian Stefanowicz. The two are seated beside Harper, to whom they make several racist innuendos.
=== Bibliography === Edwards, Giles; Isaby, Jonathan (2008). Boris v. Ken: How Boris Johnson Won London. London: Politico's. ISBN 978-1-84275-225-8. Gimson, Andrew (2012). Boris: The Rise of Boris Johnson (2nd ed.). Simon & Schuster. Nekov, Momchil (2013). От първо лице (1st ed.). Sofia: Ciela. ISBN 978-954-28143-3-7. Purnell, Sonia (2011). Just Boris: Boris Johnson: The Irresistible Rise of a Political Celebrity. London: Aurum Press Ltd. ISBN 978-1-84513-665-9.
The DSCC also called upon Republican Senators John Boozman of Arkansas and Roy Blunt of Missouri (who received $11,000 and $5,000, respectively, from Hastert's PAC in recent years) to return or donate the funds. On May 29, 2015, White House Press Secretary Josh Earnest stated in response to a reporter's question that "there is nobody here" at the White House "who derives any pleasure from reading about the former Speaker's legal troubles at this point". On the same day, House Speaker John Boehner, Republican of Ohio, issued a statement saying: "The Denny I served with worked hard on behalf of his constituents and the country. I'm shocked and saddened to learn of these reports." On May 30, 2015, Illinois's other senator, Dick Durbin, a Democrat, stated:
== Features == Each issue includes a "Making-of" article on a particular game, usually including an interview with one of the original developers. Issue 143 introduced the "Time Extend" series of retrospective articles. Like the "making-of" series, each focuses on a single game and, with the benefit of hindsight, gives an in-depth examination of its most interesting or innovative attributes. "Codeshop" examines more technical subjects such as 3D modelling programs or physics middleware, while "Studio Profile" and "University Profile" are single-page summaries ("like Top Trumps, but for game dev") of particular developers or publishers, and game-related courses at higher education institutions. Although an overall list of contributors is printed in each issue's indicia, the magazine typically has not used bylines to credit individual writers to specific reviews and articles, instead only referring to the anonymous Edge as a whole. Since 2014, some contributed features are credited with a byline. The magazine's regular columnists have been consistently credited throughout the magazine's run. The current columnists are James Leach, Clint Hocking and Tadhg Kelly. In addition, several columnists appear toward the beginning of the magazine to talk about the game industry as a whole, rather than focusing on specific game design topics. They are Trigger Happy author Steven Poole, Leigh Alexander, and Brian Howe, whose parody article section "You're Playing It Wrong" began with the new redesign.
=== Dementia and stroke === Selegiline has also been used off-label as a palliative treatment for dementia in Alzheimer's disease. However, its clinical effectiveness is limited or lacking for this use. It was also ineffective in the treatment of Lewy body dementia. Selegiline has been used to support motor rehabilitation in stroke recovery, but evidence for this use is inadequate and no recommendation can be made for or against it.
Sources: en.wikipedia.org
Berlin and Ripon joined the South Central Conference, Waupun became members of the Capitol Conference, Winneconne was accepted into the Bay Conference and the remaining three schools (Kettle Moraine Lutheran, Kewaskum and Plymouth) combined with four other schools (Port Washington, Sheboygan South, West Bend East and West Bend West) to form the Glacier Trails Conference.
They were characterized by producing flowers in spring on the previous year's wood, and often again in summer or early autumn on the current year's growth. The former Fortunei Group (also known as Florida Group, although it had nothing to do with C. florida) comprised cultivars with double or semi-double flowers that were produced on the previous year's growth in spring. Hybridization has made it impossible to keep the original Groups separate: there are a number of cultivars that produce both single and double flowers, or that only produce semi-double or double flowers under certain conditions. Late Large-flowered Group: Comprises the former Lanuginosa Group and Jackmanii Group. Cultivars of the Lanuginosa Group were derived mainly from C. lanuginosa, either directly or indirectly. The Jackmanii Group covered cultivars produced from a cross between C. viticella (or a derivative therefrom) and a member of the Patens Group. Both Groups produce their flowers on the current year's growth in summer and autumn. It is often impossible to say whether a cultivar belongs to the Lanuginosa Group or to the Jackmanii Group, due to hybridization and/or lack of information on the parentage, so it is not possible to maintain these Groups.
Neutrons produced by fission of 238U have lower energies than the original neutron (they behave as in an inelastic scattering), usually below 1 MeV (i.e., a speed of about 14,000 km/s), the fission threshold to cause subsequent fission of 238U, so fission of 238U does not sustain a nuclear chain reaction. Fast fission of 238U in the secondary stage of a thermonuclear weapon, due to the production of high-energy neutrons from nuclear fusion, contributes greatly to the yield and to fallout of such weapons. Fast fission of 238U tampers has also been evident in pure fission weapons. The fast fission of 238U also makes a significant contribution to the power output of some fast-neutron reactors.
=== Taxes on tips === The No Tax on Tips provisions only reduce federal income tax liability and do not affect tax liability for purposes of the Federal Insurance Contributions Act, which funds Social Security and Medicare, or any other federal, state, or local tax law. The new provision is expected to benefit roughly two thirds of tipped workers. Workers would still need to report tips as taxable income, but the deduction can reduce the federal tax liability otherwise owed.
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.